Screener
Zevra Therapeutics, Inc. ZVRA Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $847.71M.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s market capitalization?
- Zevra Therapeutics, Inc. (ZVRA) reported market capitalization of $847.71M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s market capitalization changed year-over-year?
- Zevra Therapeutics, Inc.'s market capitalization increased by 69.4% year-over-year, from $500.32M to $847.71M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s market capitalization has grown at a 59.0% compound annual growth rate (CAGR), from $49.56M to $504.43M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Zevra Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude